An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
about
Oxytocin receptor antagonists for inhibiting preterm labourOxytocin receptor antagonists for inhibiting preterm labourThe uterine myocyte as a target for prevention of preterm birthShort-term tocolytics for preterm delivery - current perspectivesTocolysis for inhibiting preterm birth in extremely preterm birth, multiple gestations and in growth-restricted fetuses: a systematic review and meta-analysisAbdominal surgery in pregnancy--an interdisciplinary challengeIs the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?Critical appraisal and clinical utility of atosiban in the management of preterm labor.A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.Management of preterm labor: atosiban or nifedipine?Tocolytic therapy for preterm delivery: systematic review and network meta-analysisTocolysis for preterm labor: expert opinion.Tocolysis for acute preterm labor: does anything work.Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat.Nifedipine in the management of preterm labor: a systematic review and metaanalysisDevelopment and clinical experience with the new evidence-based tocolytic atosiban.An update on the controversies of tocolytic therapy for the prevention of preterm birth.The case for tocolysis in threatened preterm labour.The development and introduction of anti-oxytocic tocolytics.Preterm delivery: an overview.Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.Recent pharmacological advances in the treatment of preterm membrane rupture, labour and delivery.Adverse effects of tocolytic therapy.Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists.Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysisEffect of low-intensity focused ultrasound on endothelin-1, nitrogen monoxide and oxytocin receptor in the uterine tissues of Sprague-Dawley rats following abortion.Clinical practice evaluation of atosiban in preterm labour management in six European countries.The management of preterm labour.The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.Developments in the pharmacotherapeutic management of spontaneous preterm labor.Spasmodic versus spasmolytic activities of Euphorbia spinidens extract on rat isolated uterus.Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour.A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranesTransdermal nitroglycerin for the treatment of preterm labor: a systematic review and metaanalysis.Medical Transfer of Patients in Preterm Labor: Treatments and Tocolytics.The safety of tocolytics used for the inhibition of preterm labour.Early and late preterm delivery rates - a comparison of differing tocolytic policies in a single urban population.Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging studyThe effect of oxytocin and an oxytocin antagonist on the human myometrial proteome.Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro.
P2860
Q24194079-1A6070FE-63D8-4FF1-A8C2-6CC2775B05E2Q24246646-B852DA98-D996-436E-AC88-D6B714AB9B0BQ26864122-0E00EF1F-8A12-4BE2-AE66-921B87800A6CQ26995337-516FC99F-3CED-412B-87EF-5102F321E94EQ28078912-317C1422-7650-4CC7-BDB3-4AB87F2904E3Q30317134-048DD3C3-B0CE-4922-AFF1-F849CA45B84FQ33287750-EB060DAA-804E-4BA0-8AA8-E26ADC6A86BAQ33817796-6BA91174-C1AE-498A-BD36-DE26FA35482AQ34119248-C7FE8C30-CB36-4628-AFAD-3C48EC90A4CAQ34272127-C80ABBFB-D92A-459B-9384-9D587CABBE19Q34304826-B9688C6A-2DB9-402C-AD23-DBB93A1C396FQ34395388-793BFF37-2514-4C79-A434-7D2F821D7D0BQ34427660-5133446B-AF5C-4C01-9E7B-78AA1348BA8CQ34613868-0DB228D7-DEAC-4157-9F75-794542F162F5Q34626694-26F12A94-6DEA-4834-9100-50771521B800Q34792360-213A8D85-252F-4382-952A-6E58BFDF84A2Q35064290-6E2F1283-5E06-46A6-BF52-6E023B01B006Q35134333-90D06661-FE86-46E5-BE35-FC14847F60C5Q35134341-53D3E9CC-721C-4295-9B3F-709E4E8B5D77Q35171814-1AEDBA82-5741-42EC-BAC8-1AD56964BCF5Q35603917-0D8B381A-01D9-4171-ACFB-CC367B5F92BFQ35871864-9418B762-84BB-4CD3-98DF-C6F60491BA4AQ36044506-6AACFB3D-E1C2-448D-8A7E-8F2E4F402C21Q36095654-1E6D83E1-B0C5-4BDE-A811-509E10E520B1Q36487287-D887E8DF-9ED1-4223-8FAF-61B4DED35576Q36639966-67C3AB10-BCB1-428A-80DE-2262B9767A10Q36700897-5BB70C3A-F828-41B5-A468-F12C404E7EA4Q36751536-B202657A-A923-461F-9D5D-189E59F5D568Q36821366-D483766D-BDFE-4EC3-BA94-56332DEAE60AQ37142064-A0F39EFA-6CF2-4032-939C-2AC104C305F5Q37517659-E8DBAC1B-2377-4BE4-A214-F9A73C086CFAQ37583699-0105DD15-9737-4918-9AF9-0FCE0AAA9679Q37637664-0CD7CBF6-5A66-4A67-A208-7084D8A44D2EQ37680562-71B1B071-E067-4456-8693-68EFE05C92FBQ38242895-E28B5036-B13D-4290-9821-9B0F7AED2622Q38829657-CCC9F9DA-73F8-4A6B-B974-7955EE9C474DQ40031794-C972A679-1864-44D4-9543-529734E55B75Q41195723-ABF0B340-46AB-4EEC-B9A4-72BF9CA2C4FCQ43273925-AC36E529-43F2-4008-B559-E20A27D3CB12Q43742236-CF2042DB-A514-47FC-92EF-39ED3112C996
P2860
An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
An oxytocin receptor antagonis ...... d trial with tocolytic rescue.
@en
An oxytocin receptor antagonis ...... d trial with tocolytic rescue.
@nl
type
label
An oxytocin receptor antagonis ...... d trial with tocolytic rescue.
@en
An oxytocin receptor antagonis ...... d trial with tocolytic rescue.
@nl
prefLabel
An oxytocin receptor antagonis ...... d trial with tocolytic rescue.
@en
An oxytocin receptor antagonis ...... d trial with tocolytic rescue.
@nl
P2093
P921
P356
P1476
An oxytocin receptor antagonis ...... d trial with tocolytic rescue.
@en
P2093
G J Valenzuela
G Shangold
G W Creasy
J C Veille
L Sanchez-Ramos
P304
P356
10.1067/MOB.2000.95834
P407
P577
2000-05-01T00:00:00Z